Breast cancer is the most common cancer among women in the United States and results in over 42,000 deaths annually. Although breast cancer appears most frequently in women over 40 years of age, it is the result of multiple molecular alterations, the first of which occurs in teenage years. The mouse mammary tumor system is a classic example of multiple stage tumorigenesis. It is the long term objectives of this research program to detect and analyze the molecular alterations associated with the early stages of mammary tumorigenesis. Three experimental strategies are proposed to achieve these goals. A gene expression screen utilizing polymerase chain reaction methodologies will be used to identify unique genes associated with preneoplastic hyperplasia and tumorigenic potential. Secondly, the expression of the unique genes as well as genes wnt5A, wnt5B and bcl-l will be examined by RNA Northern and slot blots in order to assess the significance and role of these genes in mammary preneoplastic and neoplastic transformation. When feasible, protein expression will be evaluated by immuno-histochemical procedures. Finally, the ability of specific genes to alter the tumorigenic process will be assessed by transfection methods into mammary epithelial cells in vitro and analyzed by growth patterns in vivo and in vitro. The results should identify specific genes associated with the early stages of mammary epithelial cell transformation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA047112-06A1
Application #
2092428
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1988-04-01
Project End
1998-11-30
Budget Start
1993-12-17
Budget End
1994-11-30
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Medina, D (2000) The preneoplastic phenotype in murine mammary tumorigenesis. J Mammary Gland Biol Neoplasia 5:393-407
Stickeler, E; Kittrell, F; Medina, D et al. (1999) Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18:3574-82
Bonnette, S G; Kittrell, F S; Stephens, L C et al. (1999) Interactions of apoptosis, proliferation and host age in the regression of the mouse mammary preneoplasia, TM3, carrying an unusual mutation in p53. Carcinogenesis 20:1715-20
Raught, B; Gingras, A C; James, A et al. (1996) Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. Cancer Res 56:4382-6
Medina, D (1996) Preneoplasia in mammary tumorigenesis. Cancer Treat Res 83:37-69
Jerry, D J; Medina, D; Butel, J S (1994) p53 mutations in COMMA-D cells. In Vitro Cell Dev Biol Anim 30A:87-9
Ozbun, M A; Medina, D; Butel, J S (1993) p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo. Cell Growth Differ 4:811-9
Zhang, L; Medina, D (1993) Gene expression screening for specific genes associated with mouse mammary tumor development. Mol Carcinog 8:123-6
Ozbun, M A; Jerry, D J; Kittrell, F S et al. (1993) p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. Cancer Res 53:1646-52
Medina, D; Kittrell, F S; Oborn, C J et al. (1993) Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells. Cancer Res 53:668-74

Showing the most recent 10 out of 15 publications